Alamos Gold Inc. operates as a gold producer in Canada, Mexico, and the United States. The company primarily explores for gold deposits. Alamos Gold Inc. was founded in 2003 and is based in Toronto, Canada.

Alamos Gold Inc. Class A

In a report released yesterday, Cosmos Chiu from CIBC maintained a Buy rating on Alamos Gold, with a price target of C$82.00. According to TipRanks...

CIBC Keeps Their Buy Rating on Alamos Gold (AGI)

Alamos Gold ( ($TSE:AGI) ) has issued an update. On June 18, 2026, Alamos Gold issued an operational update highlighting production challenges at i...

Alamos Gold Cuts 2026 Output Guidance After Young-Davidson Setbacks, Highlights Island Gold Strength

Agios Pharma ( ($AGIO) ) has issued an announcement. At its 2026 Annual Meeting of Stockholders held on June 18, 2026, Agios Pharmaceuticals’ share...

Agios Pharma Shareholders Expand Equity Plan, Reelect Directors

Agios Pharmaceuticals ($AGIO) announced an update on their ongoing clinical study. Agios Pharmaceuticals, Inc. is launching a Phase 3 trial titled ...

Agios Targets Transfusion Burden in Sickle Cell Disease With New Phase 3 Bet on Mitapivat

Gold prices rebounded on Thursday after falling in the previous session. Investors continued to assess the Federal Reserve’s interest-rate outlook ...

3 Best Gold Stocks to Watch as Markets React to the U.S.-Iran Peace Deal

An update from Amagi Media Labs Limited ( ($IN:AMAGI) ) is now available. Trading activity in Amagi Media Labs Limited has surged, with the stock e...

Exchange Seeks Clarification After Volume Spike in Amagi Media Labs

In a report released on June 15, MW Kim from J.P. Morgan maintained a Buy rating on AIA Group, with a price target of HK$112.00. The company’s shar...

AIA Group (AAIGF) Gets a Buy from J.P. Morgan

HSBC analyst maintained a Hold rating on AIA Group yesterday and set a price target of HK$81.00. The word on The Street in general, suggests a Stro...

AIA Group (AAIGF) Gets a Hold from HSBC

Analysts fell to the sidelines weighing in on Stevanato Group (STVN) and Agios Pharma (AGIO) with neutral ratings, indicating that the experts are ...

Analysts Are Neutral on Top Healthcare Stocks: Stevanato Group (STVN), Agios Pharma (AGIO)

Ainsworth Game Technology ( ($AU:AGI) ) has shared an announcement. Ainsworth Game Technology Limited announced that director Daniel Eric Gladstone...

Ainsworth Confirms Departure of Director Daniel Gladstone With No Equity Interests

An update from Abundia Global Impact Group ( ($AGIG) ) is now available. On June 9, 2026, Abundia Global Impact Group announced a 10-year strategic...

Abundia Secures Long-Term Plastics Feedstock for Cedar Port

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on McKesson (MCK) and Agios Pharma (AGIO) with bullish ...

Analysts’ Top Healthcare Picks: McKesson (MCK), Agios Pharma (AGIO)

CLSA analyst maintained a Buy rating on AIA Group on June 3 and set a price target of HK$121.00. The company’s shares closed yesterday at HK$82.25....

AIA Group (AAIGF) Receives a Buy from CLSA

Ainsworth Game Technology ( ($AU:AGI) ) has shared an announcement. Ainsworth Game Technology has overhauled its board and company secretariat afte...

Ainsworth Game Technology Overhauls Board as U.S. Licence Review Clears Subsidiary

In a report released yesterday, Josh Wolfson from RBC Capital maintained a Buy rating on Alamos Gold, with a price target of $52.00. According to T...

RBC Capital Remains a Buy on Alamos Gold (AGI)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Olema Pharmaceuticals (OLMA) and Agios Pharma (AGIO)...

Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA) and Agios Pharma (AGIO)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Agios Pharma (AGIO), Cogent Biosciences (COGT) and P...

Analysts Are Bullish on Top Healthcare Stocks: Agios Pharma (AGIO), Cogent Biosciences (COGT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Becton Dickinson (BDX), Agios Pharma (AGIO) and He...

Analysts Offer Insights on Healthcare Companies: Becton Dickinson (BDX), Agios Pharma (AGIO) and Healthequity (HQY)

Agios Pharmaceuticals ($AGIO) announced an update on their ongoing clinical study. The phase 3 study “A Phase 3, Double-Blind, Randomized, Placebo-...

Agios Extends Mitapivat into Pediatric Thalassemia, Opening a New Long-Term Growth Path

Agios Pharmaceuticals ($AGIO) announced an update on their ongoing clinical study. The phase 3 study titled “A Phase 3, Double-Blind, Randomized, P...

Agios Advances Pediatric Mitapivat Trial in Transfusion-Dependent Thalassemia: What Investors Should Watch

An update from Alamos Gold ( ($TSE:AGI) ) is now available. Alamos Gold Inc. reported the results of its Annual General Meeting of Shareholders hel...

Alamos Gold Shareholders Back Board, Auditor and Pay Plan at May 28 AGM

Ainsworth Game Technology ( ($AU:AGI) ) has issued an announcement. Ainsworth Game Technology used its 2026 AGM to brief shareholders on a year mar...

Ainsworth Resets Strategy After Corporate Turmoil as Asia-Pacific Growth Lifts Revenue

Ainsworth Game Technology ( ($AU:AGI) ) just unveiled an update. Ainsworth Game Technology has released the voting results of its 2026 annual gener...

Ainsworth Hit With First Strike on Pay at 2026 AGM

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Clinuvel Pharmaceuticals (CLVLF) and Agios Pharma (A...

Analysts Offer Insights on Healthcare Companies: Clinuvel Pharmaceuticals (OtherCLVLF) and Agios Pharma (AGIO)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bicara Therapeutics Inc. (BCAX), Agios Pharma (AGIO)...

Analysts Are Bullish on These Healthcare Stocks: Bicara Therapeutics Inc. (BCAX), Agios Pharma (AGIO)

An announcement from Ainsworth Game Technology ( ($AU:AGI) ) is now available. Ainsworth Game Technology expects profit before tax of about $1 mill...

Current Quarter	$0.65	Next Quarter	$0.66
Current Year	$2.46	Next Year	$3.12
QoQ Growth	+1.5%	YoY Growth	+26.8%
3Y EPS CAGR	+1.9%	Target Price	$59.87
Consensus	Buy	Upside	+64.7%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AGI	$36.34	-2.60%	5.94M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AGI	$36.34	-2.6%	5.94M
3
4
5
6

AGI

AGI

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Alamos Gold Inc. Class A Data in Excel

Get Alamos Gold Inc. Class A Data in Excel